Actionability and scope should determine the extent of counselling for presymptomatic genetic testing

Zimmermann Bettina^*, Starke Georg, Shaw David, Elger Bernice, Kone Insa

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Keywords

@article{9f6d820d22b54aeda50ee3a9e5f1119b,

title = "Actionability and scope should determine the extent of counselling for presymptomatic genetic testing",

keywords = "FAMILY-HISTORY, BREAST, RISK",

author = "Zimmermann Bettina and Starke Georg and Shaw David and Elger Bernice and Kone Insa",

year = "2020",

month = jun,

day = "29",

doi = "10.4414/smw.2020.20274",

language = "English",

volume = "150",

journal = "Swiss Medical Weekly",

issn = "1424-7860",

publisher = "Schwabe und Co. AG",

number = "28",

}

TY - JOUR

T1 - Actionability and scope should determine the extent of counselling for presymptomatic genetic testing

AU - Bettina, Zimmermann

AU - Georg, Starke

AU - David, Shaw

AU - Bernice, Elger

AU - Insa, Kone

PY - 2020/6/29

Y1 - 2020/6/29

KW - FAMILY-HISTORY

KW - BREAST

KW - RISK

U2 - 10.4414/smw.2020.20274

DO - 10.4414/smw.2020.20274

M3 - Editorial

C2 - 32654108

SN - 1424-7860

VL - 150

JO - Swiss Medical Weekly

JF - Swiss Medical Weekly

IS - 28

M1 - 20274

ER -